Opus Holdings, Inc. (CATV)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (20.00%)
Aug 1, 2025, 1:02 PM EDT
Opus Holdings Market Cap
Opus Holdings has a market cap or net worth of $1.37 million as of August 1, 2025. Its market cap has decreased by -71.12% in one year.
Market Cap
1.37M
Enterprise Value
n/a
Revenue
758.68K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 22, 2013, Opus Holdings's market cap has decreased from 16.71M to 1.37M, a decrease of -91.77%. That is a compound annual growth rate of -19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.37M | 45.38% |
| Dec 31, 2024 | 945.62K | -88.15% |
| Dec 29, 2023 | 7.98M | 952.70% |
| Dec 30, 2022 | 758.09K | -91.16% |
| Dec 31, 2021 | 8.58M | 187.16% |
| Dec 31, 2020 | 2.99M | 36,249.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |